Tullis Health Investors Company Profile

News Articles [ 141 Associated News Articles listed on BioPortfolio]

Exagen completes $5.3M financing

Exagen Diagnostics, a commercial-stage specialty diagnostic company based in Albuquerque, N.M., has executed a capital raise of $5.3 million led by Tullis Health Investors.

Exagen Completes $5.3 Million Financing

ALBUQUERQUE, N.M., Sept. 10, 2012 /PRNewswire/ -- Exagen Diagnostics, a commercial-stage specialty diagnostic company, today announced that it has executed a capital raise of $5.3 million...

Michael Cleary Joins Tullis Health Investors as Director of Investor Relations and Marketing

Tullis Health Investors (“Tullis”), a private equity and venture capital fund manager which oversees a family of funds focused on investments in biotech, pharmaceutical, medic...

[Exagen] raises $5.3mm through late-stage round

[Exagen Diagnostics Inc.] (genomic marker tests for diagnostic and drug development use) raised $5.3mm through an undisclosed late-stage round. The company completed a Series C round last June. For th...

Investors Are from Mars. Entrepreneurs Are from Venus

By Michelle Snyder Last year was a banner year for digital health, as the market saw significant growth in funding, bigger deals and new investors entering the space. So what’s in store for 20...

National Health Investors to pay fourth quarter dividend of $0.67 per common share

National Health Investors, Inc. announced today that it will pay a fourth quarter dividend of $.67 per common share to shareholders of record on December 31, 2012 and payable on January 31, 2013.

Investors plot hedges for US healthcare law ruling

NEW YORK (Reuters) - Investors could be excused for avoiding health insurance and hospital stocks as a U.S. Supreme Court decision nears on President Barack Obama's healthcare overhaul law - an ou...

National Health Investors acquires senior living campus in Loma Linda, California

National Health Investors, Inc. announced today the $12 million acquisition of a 181-unit senior living campus in Loma Linda, California funded from available cash and from borrowings on NHI's revolvi...

Drugs and Medications [ 83 Associated Drugs and Medications listed on BioPortfolio]

Cardinal health hand sanitizer with aloe [Cardinal Health]

Gas relief [CARDINAL HEALTH]

Leader 44-137

Tavist [Novartis Consumer Health, Inc.]

Drug Facts

Leader tioconastat 1 [Cardinal Health]

Cardinal Health Tioconastat® 1 Drug Facts

Moisturizing sunblock [Vienna Health and Beauty Corporation]

Drug Facts

PubMed Articles [ 11 Associated PubMed Articles listed on BioPortfolio]

John ivor tullis.

Industry progress report on neuro-oncology: a biotech update.

With steadily rising revenue and large numbers of clinical trials utilizing novel treatment strategies, the field of neuro-oncology is at the core of the growing cancer therapy industry. In June 2012,...

Erratum.

Erratum Murthy et al., "The synthetic GLP-I receptor agonist, exenatide, reduces intimal hyperplasia in insulin resistant rats" Diabetes & Vascular Disease Research 2010 7(2):138-144. In the above pap...

Fostering a new dialogue to improve access to finance for European biopharma SMEs.

This article reviews the current economic crisis as it impacts upon European biopharma SMEs and their ability to secure investment and funding. In particular it presents an analysis of a broader, pre-...

The normalisation of terror: the response of Israel's stock market to long periods of terrorism.

Man-made disasters such as acts of terrorism may affect a society's resiliency and sensitivity to prolonged physical and psychological stress. The Israeli Tel Aviv stock market TA-100 Index was used a...

Clinical Trials [ 1100 Associated Clinical Trials listed on BioPortfolio]

Trial Embedded in an Electronic Personal Medical Health Records

This is a research study to determine if a personal health record, called myHERO, will help improve health. A personal health record is a secure internet (also called online) tool that con...

Medical Self-Management for Improving Health Behavior Among Individuals in Community Mental Health Settings

This study will evaluate the effectiveness of a medical illness self-management program in improving the health and health behavior of people who are receiving care at a community mental h...

Using Tailored Emails to Motivate Healthy Behavior Among Employees

The purpose of this research is to evaluate the efficacy of a multi-component email health promotion program on employee adoption of health promoting behaviors and secondarily on health st...

Randomised Trial of Health Coaching in Secondary Prevention of Diabetes and Heart Disease

A randomised trial with individual patients as units of observation will be carried out. Health coaching is used to modify health behaviour and thus improve disease control and health stat...

Oral Health in Adults: Association With Attitude, Literacy and Psychological Factors

The purpose of this study to investigate attitude, oral health literacy and psychological factors in order to evaluate if these factors are important for oral health in adults. The hypoth...

Companies [ 1909 Associated Companies listed on BioPortfolio]

Tullis Health Investors

Tullis Health Investors (“THI”) manages a family of funds and investments, each focused exclusively on healthcare. THI has been a pioneer in healthcare-focused venture...

Atritech, Inc.

Atritech is a privately held company based in Plymouth, Minnesota. Major investors in Atritech include Split Rock Partners, Thomas, McNerney and Partners, Prism Venture Partners, Tullis Health Invest...

DBL Investors

DBL Investors is a pioneer of double bottom line venture capital, a new and growing field of investing that seeks to optimize both financial return (First Bottom Line) and positiv...

MTS Health Investors, LLC

Health Investors, Inc.